Advertisement

Other Viral Arthritides

  • Luis E. Vega
  • Luis R. Espinoza
Chapter

Abstract

Rheumatic manifestations may follow a variety of viral infections. These viral infections may induce septic and reactive arthritis, and may be associated with chronic inflammatory joint diseases. New molecular techniques allow us to identify and isolate these viruses. Non-steroidal anti-inflammatory drugs or short courses of glucocorticoids have been used and reported to be of benefit. Some viruses are associated with the development of autoimmune inflammatory joint diseases, that is, systemic lupus erythematosus, Sjögren’s syndrome, and rheumatoid arthritis.

Keywords

Viral arthritides Rubella arthritis Epstein–Barr arthritis Adenovirus-induced arthritis Varicella-zoster arthritis Mumps arthritis Herpes simplex arthritis CMV arthritis 

References

  1. 1.
    Ahmad N, Drew WL, Lagunoff M. Pathogenic viruses. In: Ryan Kenett J, editor. Sherris medical microbiology. 7th ed: Mc Graw-Hill Education; 2018.Google Scholar
  2. 2.
    Rhee EG, Johanssen EC, Crumpaker OS, Gershon AA, Witley RJ, Schiffer JT. Viruses. In: Bennett JE, Dolin R, Blaser MJ, editors. Mandell, Douglas, and Bennett’s principles and practice of infectious diseases book. 8th ed: Elsevier Saunders; 2015.Google Scholar
  3. 3.
    Lambert N, Strebel P, Orenstein W, Icenogle J, Poland GA. Rubella. Lancet. 2015;385:2297–307.PubMedPubMedCentralCrossRefGoogle Scholar
  4. 4.
    Fry J, Dillane JB, Fry L. Rubella virus. Br Med J. 1962;2(5320):1666–7.CrossRefGoogle Scholar
  5. 5.
    Loudon IS. Polyarthritis in rubella. Br Med J. 1953;1:1388.PubMedCentralCrossRefPubMedGoogle Scholar
  6. 6.
    Kantor T, Tannes M. Rubella arthritis and rheumatoid arthritis. Arthritis Rheum. 1962;5:378–83.PubMedCrossRefGoogle Scholar
  7. 7.
    Lee PR, Barnett AF, Scholer JF. Rubella arthritis—a study of twenty cases. Calif Med. 1960;93:125–8.PubMedPubMedCentralGoogle Scholar
  8. 8.
    Chambers RJ, Bywaters EGL. Rubella synovitis. Ann Rheum Dis. 1963;22:263–8.PubMedPubMedCentralCrossRefGoogle Scholar
  9. 9.
    Yanez JE, Thompson GR, Mikkelsen WM, Bartholomew LE. Rubella arthritis. Ann Intern Med. 1966;64:772–7.PubMedCrossRefGoogle Scholar
  10. 10.
    Smith D, Guzowska J. Arthritis complicating rubella. Med J Aust. 1970;1:845–7.PubMedCrossRefGoogle Scholar
  11. 11.
    Miller WH, Curl OJ. Arthritis complicating rubella in a recent epidemic. Practitioner. 1963;190:515–7.Google Scholar
  12. 12.
    Johnston INL. Complications of rubella. BMJ. 1962;2:414.CrossRefGoogle Scholar
  13. 13.
    Hildebrandt HM, Maassab HB. Rubella synovitis in a one-year-old patient. N Engl J Med. 1966;274:1428–30.PubMedCrossRefGoogle Scholar
  14. 14.
    Best JM. Rubella vaccines: past, present and future. Epidemiol Infect. 1991;107:17–30.PubMedPubMedCentralCrossRefGoogle Scholar
  15. 15.
    Cooper LZ, Ziring PR, Weiss HJ, et al. Transient arthritis after rubella vaccination. Am J Dis Child. 1969;118:218–25.PubMedCrossRefGoogle Scholar
  16. 16.
    Horstmann DM, Liebhaber H, Kohorn EI. Post-partum vaccination of rubella-susceptible women. Lancet. 1970;2:1003–6.PubMedCrossRefGoogle Scholar
  17. 17.
    Barnes EK, Altman R, Austin SM, Dougherty WJ. Joint reactions in children vaccinated against rubella. Study II: comparison of the three vaccines. Am J Epidemiol. 1972;95:59–66.PubMedCrossRefGoogle Scholar
  18. 18.
    Dudgeon AJ, Marshall W, Peckham C. Rubella vaccinated trials in adults and children. Am J Dis Child. 1969;118:237–42.PubMedCrossRefGoogle Scholar
  19. 19.
    Spruance SL, Smith CB. Joint complications associated with derivatives of HPV-77rubella virus vaccine. Am J Dis Child. 1971;122:105–11.PubMedGoogle Scholar
  20. 20.
    Thompson G, Ferreyra A, Brackett RG. Acute arthritis complicating rubella vaccination. Arthritis Rheum. 1971;14:19–26.PubMedCrossRefGoogle Scholar
  21. 21.
    Swartz TA, Klingberg W, Goldwasser RA. Clinical manifestations, according to age, among females given HPV-77 duck embryo vaccine. Am J Epidemiol. 1971;94:246–51.PubMedCrossRefGoogle Scholar
  22. 22.
    Polk BF, Modlin JF, White JA, DeGirolami PC. A controlled comparison of joint reactions among women receiving one of two rubella vaccines. Am J Epidemiol. 1982;115:19–25.PubMedCrossRefGoogle Scholar
  23. 23.
    Tingle AJ, Yang T, Allen M, Kettyls GD, Larke RP, Schulzer M. Prospective immunological assessment of arthritis induced by rubella vaccine. Infect Immun. 1983;40:22–8.PubMedPubMedCentralGoogle Scholar
  24. 24.
    Tingle AJ, Allen M, Petty RE, Kettyls GD, Chantler JK. l Rubella-associated arthritis. I. Comparative study of joint manifestations associated with natural rubella infection and RA 27/3 rubella immunization. Ann Rheum Dis. 1986;45:110–4.PubMedPubMedCentralCrossRefGoogle Scholar
  25. 25.
    Singh VK, Tingle AJ, Schulzer M. Rubella-associated arthritis. II. Relationship between circulating immune complex levels and joint manifestations. Ann Rheum Dis. 1986;45:115–9.PubMedPubMedCentralCrossRefGoogle Scholar
  26. 26.
    Wallace RB, Liber P, Ibrahim M, lsacson P. Joint symptoms following an area-wide rubella immunization campaign--report of a survey. Am J Public Health. 1972;62:658–61.PubMedPubMedCentralCrossRefGoogle Scholar
  27. 27.
    Weibel RE, Stokes J, Buynak EB, et al. Live rubella vaccines in adults and children. Am J Dis Child. 1969;118:226–9.PubMedCrossRefGoogle Scholar
  28. 28.
    Weibel RE, Stokes J, Buynak EB, et al. Influence of age on clinical response to HPV-77 rubella vaccine duck. JAMA. 1972;222:805–7.PubMedCrossRefGoogle Scholar
  29. 29.
    Lerman SJ, Nankervis GA, Heggie AD. Immunologic response, virus exception, and joint reaction with Rubella vaccine. Ann Intern Med. 1971;74:67–73.PubMedCrossRefGoogle Scholar
  30. 30.
    Thompson GR, Weiss JJ, Shilis JL. Intermittent arthritis following rubella vaccination. Am J Dis Child. 1973;125:526–30.PubMedCrossRefPubMedCentralGoogle Scholar
  31. 31.
    Ogra PL, Herd KJ. Arthritis associated with induced rubella infection. J Immunol. 1971;107:810–3.PubMedPubMedCentralGoogle Scholar
  32. 32.
    Weibel RE, Stokes J, Buynak EB. Rubella vaccination in adults females. N Engl J Med. 1969;280:682–5.PubMedCrossRefPubMedCentralGoogle Scholar
  33. 33.
    Spruance SL, Metcalf R, Smith CB, et al. Chronic arthropathy associated with rubella vaccination. Arthritis Rheum. 1977;20:741–7.PubMedCrossRefPubMedCentralGoogle Scholar
  34. 34.
    Spruance SL, Klock LE, Bailey A, et al. Recurrent joint symptom in children vaccinated with HPV-77DK 12 rubella vaccine. J Pediatr. 1972;80:413–7.PubMedCrossRefPubMedCentralGoogle Scholar
  35. 35.
    Grahame R, Armstrong R, Simmons N, Wilton JM, Dyson M, Laurent R, Millis R, Mims CA. Chronic arthritis associated with the presence of intrasynovial rubella virus. Ann Rheum Dis. 1983;42:2–13.PubMedPubMedCentralCrossRefGoogle Scholar
  36. 36.
    Chantler JK, Tingle AJ, Petty RE. Persistent rubella virus infection associated with chronic arthritis in children. N Engl J Med. 1985;313:1117–23.PubMedCrossRefPubMedCentralGoogle Scholar
  37. 37.
    Bosma TJ, Etherington J, O’Shea S, Corbett K, Cottam F, Holt L, Banatvala JE, Best JM. Rubella virus and chronic joint disease: is there an association? J Clin Microbiol. 1998;36:3524–6.PubMedPubMedCentralGoogle Scholar
  38. 38.
    Lynch JP 3rd, Kajon AE. Adenovirus: epidemiology, global spread of novel serotypes, and advances in treatment and prevention. Semin Respir Crit Care Med. 2016;37:586–602.PubMedCrossRefPubMedCentralGoogle Scholar
  39. 39.
    Lion T. Adenovirus infections in immunocompetent and immunocompromised patients. Clin Microbiol Rev. 2014;27:441–62.PubMedPubMedCentralCrossRefGoogle Scholar
  40. 40.
    Scott MK, Chommanard C, Lu X, et al. Human adenovirus associated with severe respiratory infection, Oregon, USA, 2013–2014. Emerg Infect Dis. 2016;22:1044–51.PubMedPubMedCentralCrossRefGoogle Scholar
  41. 41.
    Centers for Disease Control. Acute respiratory disease associated with adenovirus serotype 14—four states, 2006-2007. MMWR Morb Mortal Wkly Rep. 2007;56:1181–4.Google Scholar
  42. 42.
    Lamson DM, Kajon A, Shudt M, Girouard G, St George K. Detection and genetic characterization of adenovirus type 14 strain in students with influenza-like illness, New York, USA, 2014–2015. Emerg Infect Dis. 2017;23:1194.PubMedPubMedCentralCrossRefGoogle Scholar
  43. 43.
    Panush RS. Adenovirus arthritis. Arthritis Rheum. 1974;17:534–6.PubMedCrossRefPubMedCentralGoogle Scholar
  44. 44.
    Utsinger PD. Immunologic study of arthritis associated with adenovirus infection. Arthritis Rheum. 1977;20:138.Google Scholar
  45. 45.
    Meyer-Bahlburg A, Dressler F, Baumann U. Chronic arthritis in a boy with Cernunnos immunodeficiency. Clin Immunol. 2014;154:47–8.PubMedCrossRefPubMedCentralGoogle Scholar
  46. 46.
    Shetty AK, Treynor E, Hill DW, Gutierrez KM, Warford A, Baron EJ. Comparison of conventional viral cultures with direct fluorescent antibody stains for diagnosis of community-acquired respiratory virus infections in hospitalized children. Pediatr Infect Dis J. 2003;22:789–94.PubMedCrossRefPubMedCentralGoogle Scholar
  47. 47.
    Terletskaia-Ladwig E, Leinmuller M, Schneider F, Meier S, Enders M. Laboratory approaches to the diagnosis of adenovirus infection depending on clinical manifestations. Infection. 2007;35:438–43.PubMedCrossRefPubMedCentralGoogle Scholar
  48. 48.
    Kidd A, Jonsson M, Garwicz D, et al. Rapid subgenus identification of human adenovirus isolates by a general PCR. J Clin Microbiol. 1996;34:622–7.PubMedPubMedCentralGoogle Scholar
  49. 49.
    Xu W, Mcdonough MC, Erdman DD. Species-specific identification of human adenoviruses by a multiplex PCR assay. J Clin Microbiol. 2000;38:4114–20.PubMedPubMedCentralGoogle Scholar
  50. 50.
    Buckwalter SP, Teo R, Espy MJ, Sloan LM, Smith TF, Pritt BS. Real-time qualitative PCR for 57 human adenovirus types from multiple specimen sources. J Clin Microbio. 2012;50:766–71.CrossRefGoogle Scholar
  51. 51.
    Ganzenmueller T, Heim A. Adenoviral load diagnostics by quantitative polymerase chain reaction: techniques and application. Rev Med Virol. 2012;22:194–208.PubMedCrossRefPubMedCentralGoogle Scholar
  52. 52.
    Jeulin H, Salmon A, Bordigoni P, Venard V. Comparison of in-house real time quantitative PCR to the Adenovirus R-Gene kit for determination of adenovirus load in clinical samples. J Clin Microbiol. 2010;48:3132–7.PubMedPubMedCentralCrossRefGoogle Scholar
  53. 53.
    De Paschale M, Clerici P. Serological diagnosis of Epstein-Barr virus infection: problems and solutions. World J Virol. 2012;1:31–43.PubMedPubMedCentralCrossRefGoogle Scholar
  54. 54.
    Bernstein A. Infectious mononucleosis. Medicine. 1940;19:85–159.CrossRefGoogle Scholar
  55. 55.
    Chervenick PA. Infectious mononucleosis. Dis Mon. 1974:1–29.CrossRefGoogle Scholar
  56. 56.
    Adebonojo FO. Monoarticular arthritis: an unusual manifestation of infectious mononucleosis. Clin Pediatr (Phila). 1972;11:549–50.CrossRefGoogle Scholar
  57. 57.
    Berger RG, Raab-Traub N. Acute monoarthritis from infectious mononucleosis. Am J Med. 1999;107:177–8.PubMedCrossRefPubMedCentralGoogle Scholar
  58. 58.
    Pollack S, Enat R, Barzilai D. Monoarthritis with heterophil-negative infectious mononucleosis. Case of an older patient. Arch Intern Med. 1980;140:1109–11.PubMedCrossRefPubMedCentralGoogle Scholar
  59. 59.
    Gómez N, Rey R, Ibáñez J. Acute oligoarthritis and infection by Epstein-Barr virus. Enferm Infecc Microbiol Clin. 1998;16:440–1.PubMedPubMedCentralGoogle Scholar
  60. 60.
    Feced CM, Fernández M, Robustillo M, De la Morena I, Alegre JJ. Joint involvement secondary to Epstein-Barr virus. Reumatol Clin. 2016;12:100–2.CrossRefGoogle Scholar
  61. 61.
    Urman JD, Bobrove AM. Acute polyarthritis and infectious mononucleosis. West J Med. 1982;136:151–3.PubMedPubMedCentralGoogle Scholar
  62. 62.
    Sigal LH, Steere AC, Niederman JC. Symmetric polyarthritis associated with heterophile-negative infectious mononucleosis. Arthritis Rheum. 1983;26:553–6.PubMedCrossRefGoogle Scholar
  63. 63.
    Evans ASEB. Virus antibody in systemic lupus erythematosus. Lancet. 1971;1:1023–4.PubMedCrossRefGoogle Scholar
  64. 64.
    Toussirot E, Roudier J. Epstein-Barr virus in autoimmune diseases. Best Pract Res Clin Rheumatol. 2008;22:883–96.PubMedCrossRefPubMedCentralGoogle Scholar
  65. 65.
    Esposito S, Bosis S, Semino M, et al. Infections and systemic lupus erythematosus. Eur J Clin Microbiol Infect Dis. 2014;33:1467–75.PubMedCrossRefPubMedCentralGoogle Scholar
  66. 66.
    Fattal I, Shental N, Molad Y, et al. Epstein-Barr virus antibodies mark systemic lupus erythematosus and scleroderma patients negative for anti-DNA. Immunology. 2014;141:276–85.PubMedPubMedCentralCrossRefGoogle Scholar
  67. 67.
    Rasmussen NS, Draborg AH, Nielsen CT, et al. Antibodies to early EBV, CMV, and HHV6 antigens in systemic lupus erythematosus patients. Scand J Rheumatol. 2015;44:143–9.PubMedPubMedCentralCrossRefGoogle Scholar
  68. 68.
    Ball RJ, Avenell A, Aucott L, Hanlon P, Vickers MA. Systematic review and meta-analysis of the sero-epidemiological association between Epstein-Barr virus and systemic lupus erythematosus. Arthritis Res Ther. 2014;16:R3.CrossRefGoogle Scholar
  69. 69.
    Croia C, Astorri E, Murray-Brown W, et al. Implication of Epstein-Barr virus infection in disease-specific autoreactive B-cell activation in ectopic lymphoid structures of Sjogren’s syndrome. Arthritis Rheumatol. 2014;66:2545–57.PubMedCrossRefPubMedCentralGoogle Scholar
  70. 70.
    Kivity S, Arango MT, Ehrenfeld M, et al. Infection and autoimmunity in Sjogren’s syndrome: a clinical study and comprehensive review. J Autoimmun. 2014;51:17–22.PubMedCrossRefGoogle Scholar
  71. 71.
    Erre GL, Mameli G, Cossu D, et al. Increased Epstein-Barr virus DNA load and antibodies against EBNA1 and EA in sardinian patients with rheumatoid arthritis. Viral Immunol. 2015;28:385–90.PubMedCrossRefGoogle Scholar
  72. 72.
    Ball RJ, Avenell A, Aucott L, Hanlon P, Vickers MA. Systematic review and meta-analysis of the sero-epidemiological association between Epstein-Barr virus and rheumatoid arthritis. Arthritis Res Ther. 2015;17:274.PubMedPubMedCentralCrossRefGoogle Scholar
  73. 73.
    Harley JB, Chen X, Pujato M, Miller D, Maddox A, Forney C, et al. Transcription factors operate across disease loci, with EBNA2 implicated in autoimmunity. Nat Genet. 2018;50:699–70.PubMedPubMedCentralCrossRefGoogle Scholar
  74. 74.
    Ward JR, Bishop B. Varicella arthritis. JAMA. 1970;212:1954–6.PubMedCrossRefGoogle Scholar
  75. 75.
    Fink CG, Read SJ, Giddins G, Eglin RP. Chicken pox infection (varicella zoster virus) and acute monoarthritis: evidence against a direct viral mechanism. J Clin Pathol. 1992;45:267–9.PubMedPubMedCentralCrossRefGoogle Scholar
  76. 76.
    Brook I. Varicella arthritis in childhood. Reports of 2 cases and 4 others found in the literature. Clin Pediatr (Phila). 1977;16:1156–7.CrossRefGoogle Scholar
  77. 77.
    Gibson NF, Ogden WS. Varicella arthritis. South Med J. 1986;79:1028–30.PubMedCrossRefGoogle Scholar
  78. 78.
    Bevilacqua S, Poircuitte JM, Boyer L, May T, Lascombes P, Venard V. Varicella Arthritis in Childhood: a case report and review of the literature. Pediatr Infect Dis J. 2011;30:980–2.PubMedCrossRefGoogle Scholar
  79. 79.
    Fierman AH. Varicella-associated arthritis occurring before the exanthem. Case report and literature review. Clin Pediatr (Phila). 1990;29:188–90.CrossRefGoogle Scholar
  80. 80.
    Stebbings S, Highton J, Croxson MC, Powell K, McKay J, Rietveld J. Chickenpox monoarthritis: demonstration of varicella-zoster virus in joint fluid by polymerase chain reaction. Br J Rheumatol. 1998;37:311–3.PubMedCrossRefGoogle Scholar
  81. 81.
    Chen MK, Wang CC, Lu JJ, Perng CL, Chu ML. Varicella arthritis diagnosed by polymerase chain reaction. J Formos Med Assoc. 1999;98:519–21.PubMedGoogle Scholar
  82. 82.
    Evans E, Dawes PT, Mattey DL. An unusual case of adult varicella-associated arthritis. Rheumatology (Oxford). 2000;39:806–8.CrossRefGoogle Scholar
  83. 83.
    Caranasos GJ, Felker JR. Mumps arthritis. Arch Intern Med. 1967;119:394–8.PubMedCrossRefGoogle Scholar
  84. 84.
    Solem JH. Mumps arthritis without parotitis. Scand J Infect Dis. 1971;3:173–5.PubMedCrossRefGoogle Scholar
  85. 85.
    Maris EP, Enders JF, Stokes J, Kane LW. Immunity in Mumps: IV. The Correlation of the Presence of Complement-fixing antibody and resistance to Mumps in Human Beings. J Exp Med. 1946;84:323–39.PubMedPubMedCentralCrossRefGoogle Scholar
  86. 86.
    Gordon SC, Lauter CB. Mumps arthritis. A review of the literature. Rev Infect Dis. 1984;6:338–44.PubMedCrossRefGoogle Scholar
  87. 87.
    Nikonov OS, Chernykh ES, Garber MB, Nikonova EY. Enteroviruses: classification, diseases they cause, and approaches to development of antiviral drugs. Biochemistry (Mosc). 2017;82:1615–31.CrossRefGoogle Scholar
  88. 88.
    Sanford JP, Sulkin SE. The clinical spectrum of ECHO-virus infection. N Engl J Med. 1959;261:1113–22.PubMedCrossRefGoogle Scholar
  89. 89.
    Hurst NP, Martynoga AG, Nuki G, Sewell JR, Mitchell A, Hughes GR. Coxsackie B infection and arthritis. Br Med J (Clin Res Ed). 1983;286:605.CrossRefGoogle Scholar
  90. 90.
    Rahal JJ, Millian SJ, Noriega ER. Coxsackievirus and adenovirus infection. Association with acute febrile and juvenile rheumatoid arthritis. JAMA. 1976;7(235):2496–501.CrossRefGoogle Scholar
  91. 91.
    Blotzer JW, Myers AR. Echovirus-associated polyarthritis. Report of a case with synovial fluid and synovial histologic characterization. Arthritis Rheum. 1978;21:978–81.PubMedCrossRefGoogle Scholar
  92. 92.
    Kujala G, Newman JH. Isolation of echovirus type 11 from synovial fluid in acute monocytic arthritis. Arthritis Rheum. 1985;28:98–9.PubMedCrossRefGoogle Scholar
  93. 93.
    Triantafyllopoulou A, Tapinos N, Moutsopoulos HM. Evidence for coxsackievirus infection in primary sjogren’s syndrome. Arthritis Rheum. 2004;50:2897–902.PubMedCrossRefGoogle Scholar
  94. 94.
    Gandhi MK, Khanna R. Human cytomegalovirus: clinical aspects, immune regulation, and emerging treatments. Lancet Infect Dis. 2004;4:725–38.PubMedCrossRefGoogle Scholar
  95. 95.
    Friedman HM, Pincus T, Gibilisco P, Baker D, et al. Acute monoarticular arthritis caused by herpes simplex virus and cytomegalovirus. Am J Med. 1980;69:241–7.PubMedCrossRefGoogle Scholar
  96. 96.
    Halenius A, Hengel H. Human cytomegalovirus and autoimmune disease. Biomed Res Int. 2014;2014:1–15.CrossRefGoogle Scholar
  97. 97.
    Dolcino M, Puccetti A, Barbieri A, Bason C, Tinazzi E, Ottria A, et al. Infections and autoimmunity: role of human cytomegalovirus in autoimmune endothelial cell damage. Lupus. 2015;24:419–32.PubMedCrossRefGoogle Scholar
  98. 98.
    Brna JA, Hall RF Jr. Acute monoarticular herpetic arthritis. J Bone Joint Surg. 1984;66-A:623.CrossRefGoogle Scholar
  99. 99.
    Shelley WB. Herpetic arthritis associated with disseminate herpes simplex in a wrestler. Br J Dermatol. 1980;103:209–12.PubMedCrossRefGoogle Scholar
  100. 100.
    Naraqi S, Jackson GG, Jonasson OM. Viremia with herpes simplex type 1 in adults: four nonfatal cases, one with features of chicken pox. Ann Int Med. 1976;85:165–9.PubMedCrossRefGoogle Scholar

Copyright information

© Springer Nature Switzerland AG 2019

Authors and Affiliations

  • Luis E. Vega
    • 1
  • Luis R. Espinoza
    • 2
  1. 1.Department of MedicineHospital Central de la Fuerza AéreaLimaPeru
  2. 2.LSU Health Sciences at New Orleans, Louisiana State UniversityNew OrleansUSA

Personalised recommendations